GLPG Galapagos NV

Galapagos Receives Transparency Notifications from Bank of America  

Galapagos Receives Transparency Notifications from Bank of America  

Mechelen, Belgium; March 10, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America.

Pursuant to Belgian transparency legislation1, Galapagos received transparency notifications from Bank of America Corporation on March 5 and 6, 2026. The initial notification indicates that Bank of America Corporation, as controlling entity, fell below the 5% threshold for equivalent financial instruments relating to Galapagos’ voting rights on March 3, 2026, as a result of the disposal of such instruments. A subsequent notification received on March 6, 2026 indicates that Bank of America Corporation, as controlling entity, crossed above the 5% threshold for equivalent financial instruments relating to Galapagos’ voting rights again on March 4, 2026, following the acquisition of such instruments.

On March 6, 2026, Bank of America Corporation (taking into account the holding of its affiliates) owned 335,202 voting rights and 3,489,591 equivalent financial instruments, representing together 5.80% of Galapagos’ currently outstanding 65,897,071 shares.

Summary of the transactions:

Date on which the threshold was crossedDate of notificationDirect voting rights after the transactionEquivalent financial instruments after the transactionTotal (%)

voting rights
March 5, 2026March 3, 20261.00%4.70%5.70%
March 6, 2026March 4, 20260.51%5.30%5.80%

Content of the notifications from Bank of America Corporation:

The notification dated March 6, 2026, contains the following information:

  • Date of notification: March 6, 2026
  • Date on which the threshold is crossed: March 4, 2026
  • Threshold of voting rights crossed (in %): 5%
  • Notification by: Bank of America Corporation
  • Denominator: 65,897,071
  • Reason for the notification: Acquisition or disposal of financial instruments that are treated as voting securities
  • Notified details:



A) Voting RightsPrevious notificationAfter the transaction
 # of voting rights# of voting rights% of voting rights
Holder of voting rights Linked to securitiesNot linked to securitiesLinked to securitiesNot linked to securities
Bank of America Corporation00 0.00% 
Bank of America, National Association12,44012,440 0.02% 
Merrill Lynch International101,655128,053 0.19% 
Managed Account Advisors LLC33 0.00% 
BofA Securities, Inc.530,639180,123 0.27% 
Merrill Lynch, Pierce, Fenner & Smith

Incorporated
14,46214,462 0.02% 
U.S. Trust Company of Delaware121121 0.00% 
Subtotal659,330335,202 0.51% 
 TOTAL335,20200.51%0.00%



B) Equivalent financial instrumentsAfter the transaction
Holder of equivalent financial instrumentsType of financial instrumentExpiration dateExercise period or date# of voting rights that may be acquired if the instrument is exercised% of voting rightsSettlement
Merrill Lynch InternationalRight to Recall  132,6660.20%physical
BofA Securities, Inc.Right to Recall  23,2000.04%physical
BofA Securities, Inc.Rights of Use  3,174,1354.82%physical
Merrill Lynch InternationalPhysical Call Option19/06/2026 100,0000.15%physical
Bank of America, National AssociationSwaps31/01/2028 2630.00%cash
Bank of America, National AssociationSwaps15/04/2027 14,6790.02%cash
Bank of America, National AssociationSwaps29/02/2028 8460.00%cash
Merrill Lynch InternationalSwaps15/01/2027 8,0560.01%cash
Merrill Lynch InternationalSwaps30/04/2026 12,0500.02%cash
Merrill Lynch InternationalSwaps02/07/2026 9640.00%cash
Merrill Lynch InternationalSwaps01/11/2027 5,7260.01%cash
Merrill Lynch InternationalSwaps15/04/2027 14,6790.02%cash
Merrill Lynch InternationalSwaps30/06/2026 1010.00%cash
Merrill Lynch InternationalSwaps31/03/2027 2850.00%cash
Merrill Lynch InternationalSwaps09/09/2027 9450.00%cash
Merrill Lynch InternationalSwaps29/12/2027 9960.00%cash
 TOTAL  3,489,5915.30% 



TOTAL (A&B)# of voting rights% of voting rights
 3,824,7935.80%

The chain of control has been described at the end of the notification (section 11) and can be found .

Content of the notifications from Bank of America Corporation:

The notification dated March 5, 2026, contains the following information:

  • Date of notification: March 5, 2026
  • Date on which the threshold is crossed: March 3, 2026
  • Threshold of voting rights crossed (in %): 5%
  • Notification by: Bank of America Corporation
  • Denominator: 65,897,071
  • Reason for the notification: Acquisition or disposal of financial instruments that are treated as voting securities
  • Notified details:



A) Voting RightsPrevious notificationAfter the transaction
 # of voting rights# of voting rights% of voting rights
Holder of voting rights Linked to securitiesNot linked to securitiesLinked to securitiesNot linked to securities
Bank of America Corporation00 0.00% 
Bank of America, National Association12,44012,440 0.02% 
Merrill Lynch International95,048101,665 0.15% 
Managed Account Advisors LLC33 0.00% 
BofA Securities, Inc.170,568530,639 0.81% 
Merrill Lynch, Pierce, Fenner & Smith

Incorporated
14,46214,462 0.02% 
U.S. Trust Company of Delaware121121 0.00% 
Subtotal292,642659,330 1.00% 
 TOTAL659,33001.00%0.00%



B) Equivalent financial instrumentsAfter the transaction
Holder of equivalent financial instrumentsType of financial instrumentExpiration dateExercise period or date# of voting rights that may be acquired if the instrument is exercised% of voting rightsSettlement
Merrill Lynch InternationalRight to Recall  141,6840.22%physical
BofA Securities, Inc.Right to Recall  23,2000.04%physical
BofA Securities, Inc.Rights of Use  2,776,2594.21%physical
Merrill Lynch InternationalPhysical Call Option19/06/2026 100,0000.15%physical
Bank of America, National AssociationSwaps31/01/2028 6630.00%cash
Bank of America, National AssociationSwaps15/04/2027 14,6790.02%cash
Bank of America, National AssociationSwaps29/02/2028 7410.00%cash
Merrill Lynch InternationalSwaps15/01/2027 8,0560.01%cash
Merrill Lynch InternationalSwaps30/04/2026 12,7500.02%cash
Merrill Lynch InternationalSwaps02/07/2026 1,0280.00%cash
Merrill Lynch InternationalSwaps01/11/2027 5,7260.01%cash
Merrill Lynch InternationalSwaps15/04/2027 14,6790.02%cash
Merrill Lynch InternationalSwaps30/06/2026 340.00%cash
Merrill Lynch InternationalSwaps29/01/2027 1870.00%cash
 TOTAL  3,099,6864.70% 



TOTAL (A&B)# of voting rights% of voting rights
 3,759,0165.70%

The chain of control has been described at the end of the notification (section 11) and can be found .

About Galapagos

Galapagos is a biotechnology company built to bring meaningful medicines to patients with serious diseases in therapeutic areas of unmet need. The Company combines world-class deal making expertise with capital to identify, acquire, and advance promising opportunities that have the potential to drive value for patients and shareholders. Applying a modality-agnostic asset selection approach and operational flexibility, Galapagos prioritizes oncology and immunology & inflammation programs with clear clinical proof-of-concept in emerging areas. For more information, visit  or follow us on  or .

For further information, contact Galapagos:

Investor Relations

Glenn Schulman



Media

Media

Katie Morris




1 Belgian Act of 2 May 2007 on the disclosure of major shareholdings in issuers whose shares are admitted to trading on a regulated market and regarding miscellaneous provisions, as amended from time to time.

Attachment



EN
10/03/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Galapagos NV

Jacob Mekhael
  • Jacob Mekhael

Galapagos Signs agreement with Gilead on T-cell Engager in autoimmune ...

Galapagos announced that, following Gilead entering into a definitive agreement to acquire Ouro Medicines for $1,675m in cash consideration, and up to $500m in contingent milestone payments, Galapagos and Gilead have now entered into a binding agreement to collaborate on advancing gamgertamig (BCMAxCD3 T cell engager) in autoimmune diseases. This agreement comes after the companies announced their advanced discussions on the collaboration last week. Economically, Galapagos is effectively co-fina...

Guy Sips ... (+4)
  • Guy Sips
  • Jacob Mekhael
  • Mathijs Geerts Danau
  • Wim Lewi
 PRESS RELEASE

Galapagos en Gilead gaan definitieve overeenkomst aan over samenwerkin...

Galapagos en Gilead gaan definitieve overeenkomst aan over samenwerking om een first-in-class T-cel-engagerprogramma voor auto-immuunziekten verder te ontwikkelen De nieuwe samenwerkingsstructuur levert aanzienlijk verbeterde financiële voorwaarden en flexibiliteit voor Galapagos op  Na deze transactie blijft de Vennootschap over het grootste deel van haar liquide middelen beschikken voor bijkomende strategische transacties en andere prioriteiten van kapitaalallocatie Kans om met gamgertamig een potentieel first-in-class & best-in-class T-cell-engager in auto-immuunziekten te ontwikkelen ...

 PRESS RELEASE

Galapagos and Gilead Enter into Binding Agreement to Collaborate on Ad...

Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases New collaboration structure achieves meaningfully improved financial terms and flexibility for Galapagos  Following this transaction, the Company will continue to have a majority of its cash remaining for additional strategic transactions and other capital allocation priorities Opportunity to develop a potential first-in-class & best-in-class T cell engager in autoimmune diseases with gamgertamig Management to host conference call today, March 31, 20...

 PRESS RELEASE

Galapagos Announces Nomination of Gino Santini to its Board of Directo...

Galapagos Announces Nomination of Gino Santini to its Board of Directors Subject to his election by shareholders, the Board intends to appoint Mr. Santini as Chair, succeeding Jérôme Contamine  Mr. Santini will bring extensive corporate governance, business development and industry leadership experience to the Board Mechelen, Belgium; March 26, 2026, 21:02 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced the proposed appointment of Gino Santini as a Non-Executive Independent Director, with the intention to appoint him as Chair of its Board of Directors, subject to shareholder...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch